NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Orgenesis Inc (NASDAQ: ORGS)

 
ORGS Technical Analysis
2.5
As on 1st Aug 2025 ORGS SHARE Price closed @ 1.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.72 & Strong Buy for SHORT-TERM with Stoploss of 0.48 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ORGSSHARE Price

Open 1.00 Change Price %
High 1.00 1 Day 0.94 1566.67
Low 1.00 1 Week 0.00 0.00
Close 1.00 1 Month -0.88 -46.81
Volume 100 1 Year 0.18 21.95
52 Week High 5.30 | 52 Week Low 0.00
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 173.72 -2.33%
OPEN 2.10 14.13%
EQ 0.71 82.05%
AMZN 214.75 -8.27%
NCNA 0.04 0.00%
LMDX 0.02 0.00%
BTAI 1.37 4.58%
AKTS 0.04 0.00%
AAPL 202.38 -2.50%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
HCTI 4.75 15733.33%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
ORGS 1.00 1566.67%
REDU 3.41 1075.86%
DRMA 6.45 940.32%
CTXRW 0.14 600.00%
NBSTU 12.99 220.74%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
OTRKP 0.02 -60.00%
HEPA 0.05 -58.33%
 
 
ORGS
Daily Charts
ORGS
Intraday Charts
Whats New @
Bazaartrend
ORGS
Free Analysis
 
ORGS Important Levels Intraday
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
RESISTANCE1.00
 
ORGS Forecast August 2025
4th UP Forecast1.87
3rd UP Forecast1.59
2nd UP Forecast1.42
1st UP Forecast1.25
1st DOWN Forecast0.75
2nd DOWN Forecast0.58
3rd DOWN Forecast0.41
4th DOWN Forecast0.13
 
ORGS Weekly Forecast
4th UP Forecast1.58
3rd UP Forecast1.39
2nd UP Forecast1.28
1st UP Forecast1.16
1st DOWN Forecast0.84
2nd DOWN Forecast0.72
3rd DOWN Forecast0.61
4th DOWN Forecast0.42
 
ORGS Forecast2025
4th UP Forecast11.48
3rd UP Forecast8.12
2nd UP Forecast6.04
1st UP Forecast3.96
1st DOWN Forecast-1.96
2nd DOWN Forecast-4.04
3rd DOWN Forecast-6.12
4th DOWN Forecast-9.48
 
 
ORGS Other Details
Segment EQ
Market Capital 117735200.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ORGS Address
ORGS
 
ORGS Latest News
 
Your Comments and Response on Orgenesis Inc
 
ORGS Business Profile
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland. Address: 20271 Goldenrod Lane, Germantown, MD, United States, 20876
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service